Spontaneous production of eosinophil chemotactic factors by T lymphocytes from patients with subcutaneous angioblastic lymphoid hyperplasia with eosinophilia.
暂无分享,去创建一个
M. Hirashima | H. Tsuda | K. Iyama | T. Nagai | K. Sakata | T. Kimura | T. Hiraoka | J. Ohmori | K. Tashiro
[1] M. Hirashima,et al. Difference in requirement of macrophage products for concanavalin A-induced production of eosinophil chemotactic factor and macrophage chemotactic factor from guinea pig lymphocytes in vitro. , 1984, Journal of immunology.
[2] M. Hirashima,et al. Isolation of an eosinophil chemotactic lymphokine as a natural mediator for eosinophil chemotaxis from concanavalin A-induced skin reaction sites in guinea-pigs. , 1984, Clinical and experimental immunology.
[3] M. Hirashima,et al. The mediation of tissue eosinophilia in hypersensitivity reactions. V. Comparative study of tissue eosinophilia in the skin lesions of local and systemic passive cutaneous anaphylactic reactions. , 1983, Immunology.
[4] E. Luckhurst,et al. Eosinophilia VI, spontaneous synthesis of chemokinetic, chemotactic, complement receptor‐inducing activities for eosinophils by bronchial T lymphocytes of asthmatic‐bronchitic patients , 1982, Clinical allergy.
[5] S. Takasaki,et al. A PATHOLOGICAL STUDY ON EOSINOPHILIC LYMPHFOLLICULOID GRANULOMA (KIMURA'S DISEASE) , 1981, Acta pathologica japonica.
[6] L. Lichtenstein,et al. Eosinophil chemotactic factor (ECF). II. Release from human polymorphonuclear leukocytes during phagocytosis. , 1976, Journal of immunology.
[7] L. Lichtenstein,et al. Eosinophil chemotactic factor (ECF). I. Release from polymorphonuclear leukocytes by the calcium ionophore A23187. , 1976, Journal of immunology.
[8] M. Hirashima,et al. The mediation of tissue eosinophilia in hypersensitivity reaction. I. Isolation of two different chemotactic factors from DNP-Ascaris extract-induced skin lesion in guinea-pig. , 1976, Immunology.
[9] M. Okuda,et al. Histological and immunological studies on eosinophilic granuloma of soft tissue, so‐called Kimura's disease , 1976, Clinical allergy.
[10] K. Warren,et al. The lymphokine eosinophil stimulation promoter and human schistosomiasis mansoni. , 1975, The Journal of infectious diseases.
[11] A. Kay,et al. Eosinophil chemotaxis of supernatants from cultured Hodgkin's lymph node cells. , 1975, Journal of clinical pathology.
[12] D. Colley. Eosinophils and immune mechanisms. Eosinophil stimulation promoter (ESP): a lymphokine induced by specific antigen or phytohemagglutinin. , 1973, Journal of immunology.
[13] R. Reed,et al. Subcutaneous angioblastic lymphoid hyperplasia with eosinophilia (Kimura's disease) , 1972, Cancer.
[14] M. Yoshinaga,et al. The natural mediator for PMN emigration in inflammation. 3. In vitro production of a chemotactic factor by inflammatory SH-dependent protease from serum immunoglobulin G. , 1971, Immunology.
[15] K. Austen,et al. AN EOSINOPHIL LEUKOCYTE CHEMOTACTIC FACTOR OF ANAPHYLAXIS , 1971, The Journal of experimental medicine.
[16] Ch'en Cy,et al. Eosinophilic granuloma of lymph nodes and soft tissues. Report of 21 cases. , 1962 .
[17] M. Hirashima,et al. The mediation of tissue eosinophilia in hypersensitivity reactions. IV. Production of delayed eosinophil chemotactic factor-a by peritoneal exudate cells from sensitized guinea-pigs in vitro. , 1983, Immunology.
[18] M. Hirashima,et al. A C5-derived macrophage chemotactic factor from DNP-Ascaris extract-induced skin lesion in guinea pigs. , 1983, International archives of allergy and applied immunology.
[19] H. Steen. Molecular excitations in radiation damage as studies by the radiation-induced luminescence of proteins. , 1968, Scandinavian journal of clinical and laboratory investigation. Supplementum.